Catheter placement for lysis of spontaneous intracerebral hematomas: does a catheter position in the core of the hematoma allow more effective and faster hematoma lysis?

Abstract

For the fibrinolytic therapy of intracerebral hematomas (ICH) using recombinant tissue plasminogen activator (rtPA), a catheter position in the core of the hematoma along the largest clot diameter was assumed to be optimal for an effective clot lysis. However, it never had been proven that core position indeed enhances clot lysis if compared with less optimal catheter positions. In this study, the impact of the catheter position on the effectiveness and on the time course of clot lysis was evaluated. We analyzed the catheter position using a relative error calculating the distance perpendicular to the catheter's center in relation to hematoma's diameter and evaluated the relative hematoma volume reduction (RVR). The correlation of the RVR with the catheter position was evaluated. Additionally, we tried to identify patterns of clot lysis with different catheter positions. The patient's outcome at discharge was evaluated using the Glasgow outcome score. A total of 105 patients were included in the study. The mean hematoma volume was 56 ml. The overall RVR was 62.7 %. In 69 patients, a catheter position in the core of the clot was achieved. We found no significant correlation between catheter position and hematoma RVR (linear regression, p = 0.14). Core catheter position leads to more symmetrical hematoma RVR. Faster clot lysis happens in the vicinity of the catheter openings. We found no significant difference in the patient's outcome dependent on the catheter position (linear regression, p = 0.90). The catheter position in the core of the hematoma along its largest diameter does not significantly influence the effectiveness of clot lysis after rtPA application.

• Authors: Vesna Malinova, Anna Schlegel, Veit Rohde, Dorothee Mielke
• Journal: Neurosurgical review (Neurosurg Rev) Vol. 40 Issue 3 Pg. 397-402 (Jul 2017) ISSN: 1437-2320 [Electronic] Germany
• PMID: 27726038 (Publication Type: Journal Article)

Chemical References

• Fibrinolytic Agents
• Tissue Plasminogen Activator

Topics

• Adult
• Aged
• Aged, 80 and over
• Catheterization (adverse effects, methods)
• Cerebral Hemorrhage (diagnostic imaging, therapy)
• Female
• Fibrinolytic Agents (administration & dosage, therapeutic use)
• Glasgow Outcome Scale
• Humans
• Male
• Middle Aged
• Stereotaxic Techniques
• Thrombolytic Therapy
• Tissue Plasminogen Activator (administration & dosage, therapeutic use)
• Tomography, X-Ray Computed
• Treatment Outcome